Novartis – Recall of Promacta® (eltrombopag)
May 12, 2019 - The FDA announced a consumer-level recall of some lots of Novartis’ Promacta (eltrombopag) oral suspension because of a risk of potential peanut flour contamination that occurred at a third-party contract manufacturing site.
Download PDF
